Skip to main content
. 2008 Jan 28;180(2):341–355. doi: 10.1083/jcb.200708096

Figure 3.

Figure 3.

The Mcl-1–specific Bim variant does not trigger Mcl-1 degradation. (A) Immunoblots of equivalent lysates prepared from MEFs after infection with parental retroviral vector or ones expressing wild-type BimS, BimS4E, BimS2A, BimSNoxaBH3, or Noxa itself were probed with antibodies to Mcl-1 (top), Bcl-2 (middle), or HSP70 (loading control; bottom). Levels of Mcl-1 were significantly lower if Noxa or BimSNoxaBH3 (BimS with its BH3 domain replaced with that from Noxa) is expressed. In contrast, the Mcl-1–specific BimS2A variant stabilizes Mcl-1 levels. The images were assembled and cropped from a single gel. (B) BimS2A counters Mcl-1 degradation triggered by Noxa. Equivalent lysates were prepared from Noxa- or BimS4E-overexpressing MEFs after reinfection with the inert BimS4E, Noxa, or BimS2A retroviruses, and the blots were probed for Mcl-1 or HSP70 (loading control). Note that Mcl-1 levels are significantly higher in cells expressing the Mcl-1–specific BimS2A. (C) ITC analysis of BimBH3 2A and NoxaBH3 binding to Mcl-1. BimBH3 2A binds to Mcl-1 tighter than NoxaBH3.